000 01721 a2200469 4500
005 20250517152831.0
264 0 _c20170905
008 201709s 0 0 eng d
022 _a1873-7064
024 7 _a10.1016/j.neuropharm.2017.05.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKo, Ah-Reum
245 0 0 _aTRPC6-mediated ERK1/2 phosphorylation prevents dentate granule cell degeneration via inhibiting mitochondrial elongation.
_h[electronic resource]
260 _bNeuropharmacology
_cJul 2017
300 _a120-129 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aButadienes
_xpharmacology
650 0 4 _aDisease Models, Animal
650 0 4 _aDynamins
_xmetabolism
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aMale
650 0 4 _aMitochondria
_xdrug effects
650 0 4 _aMitochondrial Dynamics
_xdrug effects
650 0 4 _aMitogen-Activated Protein Kinase 12
_xmetabolism
650 0 4 _aMuscarinic Agonists
_xtoxicity
650 0 4 _aNerve Degeneration
_xetiology
650 0 4 _aNerve Tissue Proteins
_xmetabolism
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aNitriles
_xpharmacology
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aPilocarpine
_xtoxicity
650 0 4 _aRNA, Small Interfering
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aStatus Epilepticus
_xchemically induced
650 0 4 _aTRPC Cation Channels
_xgenetics
700 1 _aKang, Tae-Cheon
773 0 _tNeuropharmacology
_gvol. 121
_gp. 120-129
856 4 0 _uhttps://doi.org/10.1016/j.neuropharm.2017.05.004
_zAvailable from publisher's website
999 _c27149047
_d27149047